# DAPSONE

NDC: 62332-551
Generic name: DAPSONE
Labeler / Manufacturer: Alembic Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 20260701

FDA application: ANDA213414

## Active ingredients

- DAPSONE: 50 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62332-551"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-551
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7249f655-1d8e-482a-889a-1e7e1a19500c